steverey  created a new article
2 yrs ·Translate

Neurodegenerative Disease Therapeutics Industry Is Estimated To Move Ahead At A Cagr Of 15.6% Over The Forecast Period | #neurodegenerative Disease Therapeutics Industry

Neurodegenerative Disease Therapeutics Industry Is Estimated To Move Ahead At A Cagr Of 15.6% Over The Forecast Period

Neurodegenerative Disease Therapeutics Industry Is Estimated To Move Ahead At A Cagr Of 15.6% Over The Forecast Period

The global neurodegenerative disease markets combine to account for USD 8.33 billion revenue in 2021, which is expected to reach USD 28.15 billion by 2030, growing at a cumulative rate of 15.6% over the forecast period.